scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1028043393 |
P356 | DOI | 10.1385/MO:19:1:43 |
P698 | PubMed publication ID | 12025890 |
P50 | author | Wolfgang Stremmel | Q50772068 |
P2093 | author name string | Andreas Teufel | |
Henning Schulze-Bergkamen | |||
Ivan Zuna | |||
Jochen Rudi | |||
P2860 | cites work | Reporting results of cancer treatment | Q29620070 |
Cisplatin, mitomycin-C, 5-fluorouracil and leucovorin combination chemotherapy (l-FCM) in locally advanced unresectable or metastatic gastric carcinoma: a phase-II study. | Q31687917 | ||
Sequential high-dose methotrexate and fluorouracil combined with doxorubicin--a step ahead in the treatment of advanced gastric cancer: a trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cooperative Grou | Q33388301 | ||
Phase II study with the combination etoposide, doxorubicin, and cisplatin in advanced measurable gastric cancer | Q33428767 | ||
Prognostic significance of CEA, CA 19-9 and CA 72-4 preoperative serum levels in gastric carcinoma. | Q34504094 | ||
Chemotherapy of carcinoma of the stomach | Q40875195 | ||
The treatment of advanced gastric cancer | Q40938936 | ||
New developments in the treatment of gastric carcinoma | Q41872774 | ||
Cancer statistics, 1990. | Q43526438 | ||
Epidemiological research in stomach cancer: progress over the last ten years | Q44089151 | ||
Etoposide, l-leucovorin and fluorouracil (ELF) regimen in metastatic gastric cancer: a phase II study | Q45237330 | ||
Prognostic value of preoperative serum levels of CEA, CA 19-9 and CA 72-4 in gastric carcinoma | Q45246256 | ||
Randomized comparison between chemotherapy plus best supportive care with best supportive care in advanced gastric cancer. | Q53604465 | ||
Phase II Study of the Etoposide, Leucovorin and Fluorouracil Combination for Patients with Advanced Gastric Cancer Unsuitable for Aggressive Chemotherapy | Q61628384 | ||
Etoposide, folinic acid, and 5-fluorouracil in carboplatin-pretreated patients with advanced gastric cancer | Q67762042 | ||
Etoposide, doxorubicin, and cisplatin chemotherapy for advanced gastric adenocarcinoma: results of a phase II trial | Q68075135 | ||
High dose folinic acid/etoposide/5-fluorouracil in advanced gastric cancer--a phase II study in elderly patients or patients with cardiac risk | Q68797100 | ||
Comparison of CA 72-4 with CA 19-9 and carcinoembryonic antigen in the serodiagnostics of gastrointestinal malignancies | Q69796759 | ||
Clinical utility of CA 72-4 serum marker in the staging and immediate post-surgical management of gastric cancer patients | Q71226064 | ||
Etoposide, leucovorin and 5-fluorouracil in advanced gastric cancer: a phase II study | Q71985971 | ||
Correlation between positive CA 72-4 serum levels and lymph node involvement in patients with gastric carcinoma | Q72309568 | ||
Efficacy of combined 5-fluorouracil and cisplatinum in advanced gastric carcinomas. A phase II trial with prognostic factor analysis | Q72904323 | ||
The roles of chemotherapy and surgery in gastric carcinoma and the influence of prognostic factors on survival | Q73466014 | ||
CEA, CA 19-9, and CA-50 in monitoring gastric carcinoma | Q73586888 | ||
Final results of a randomized phase III trial of sequential high-dose methotrexate, fluorouracil, and doxorubicin versus etoposide, leucovorin, and fluorouracil versus infusional fluorouracil and cisplatin in advanced gastric cancer: A trial of the | Q74000577 | ||
Phase II study of the modified regimen of etoposide, leucovorin and 5-fluorouracil for patients with advanced gastric cancer | Q77089988 | ||
P433 | issue | 1 | |
P921 | main subject | fluorouracil | Q238512 |
etoposide | Q418817 | ||
P304 | page(s) | 43-53 | |
P577 | publication date | 2002-01-01 | |
P1433 | published in | Medical Oncology | Q2152666 |
P1476 | title | Treatment of advanced gastric cancer with etoposide, folinic acid, and fluorouracil in the clinical setting: efficacy of therapy and value of serum tumor markers | |
P478 | volume | 19 |
Q35181089 | Docetaxel as salvage therapy in highly pretreated and drug resistant gastrointestinal carcinomas |
Q37277393 | Pancreaticoduodenectomy for advanced gastric cancer with pancreaticoduodenal region involvement |
Q36616011 | Randomised phase II evaluation of irinotecan plus high-dose 5-fluorouracil and leucovorin (ILF) vs 5-fluorouracil, leucovorin, and etoposide (ELF) in untreated metastatic gastric cancer |
Search more.